Mercator: Data Shows Netherlands Best Base for International Pharmaceutical Companies
Published on: Monday 28 March 2022
LONDON, March 29, 2022--The Netherlands has been identified as the best jurisdiction to base pharma-industry entities when taking into account cost and time efficiencies, according to data compiled by the global entity portfolio management (GEPM) leader Mercator® by Citco, in its Pharmaceutical GEPM: Special Report.